P

Inventor

GERLACH UWE

DE37 patents
⚠️ This page may combine multiple inventors who share the name “GERLACH UWE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOECHST AG

20 patents
US5849755ADec 15, 1998

3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them

HOECHST AG19 citations83
US6071953AJun 6, 2000

Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them

HOECHST AG10 citations74
US5977177ANov 2, 1999

Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them

HOECHST AG14 citations74
US5652268AJul 29, 1997

Substituted benzenesulfonylureas and-thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them

HOECHST AG10 citations74
US5607976AMar 4, 1997

Substituted benzenesulfonyl-thioureas and pharmaceutical preparations containing them

HOECHST AG14 citations74
US5637721AJun 10, 1997

Process for the preparation of cephem prodrug esters

HOECHST AG5 citations73
US5631275AMay 20, 1997

Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds

HOECHST AG6 citations73
US5550232AAug 27, 1996

Diastereomers of 1-(isopropoxycarbonyloxy) ethyl 3-cephem 4-carboxylate

HOECHST AG6 citations73
US5461043AOct 24, 1995

Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate

HOECHST AG10 citations73
US6191164B1Feb 20, 2001

Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them

HOECHST AG13 citations71
US6087399AJul 11, 2000

Sulfonamide-substituted compounds, process for their preparation, their use as a medicament or diagnostic, and a medicament comprising them

HOECHST AG7 citations63
US5880155AMar 9, 1999

Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them

HOECHST AG2 citations63
US5633239AMay 27, 1997

Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them

HOECHST AG6 citations63
US5731341AMar 24, 1998

Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds

HOECHST AG2 citations62
US5589594ADec 31, 1996

Process for the preparation of cephem prodrug esters

HOECHST AG3 citations62
US5811448ASep 22, 1998

Substituted chromanysulfonyl (thio) ureas, processing for their preparation and pharmaceutical uses thereof

HOECHST AG6 citations61
US5405844AApr 11, 1995

Tetracyclic antibiotics and processes for their preparation

HOECHST AG2 citations60
US5856338AJan 5, 1999

Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparation comprising them

HOECHST AG1 citations52
US5614623AMar 25, 1997

Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate and processes for their preparation

HOECHST AG0 citations49
US5410042AApr 25, 1995

Process for the cleavage of cephalosporin prodrug esters to 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid

HOECHST AG0 citations49

AVENTIS PHARMA GMBH

8 patents
US6953857B2Oct 11, 2005

Oxybenzamide derivatives useful for inhibiting factor Xa or viia

AVENTIS PHARMA GMBH69 citations98
US6221866B1Apr 24, 2001

Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament, and pharmaceutical formulations containing them

AVENTIS PHARMA GMBH69 citations96
US6177449B1Jan 23, 2001

Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them

AVENTIS PHARMA GMBH21 citations84
US6335363B1Jan 1, 2002

Use of inhibitors of the KQTI channel and methods of controlling and treating diseases caused by helminths and ectoparasites

AVENTIS PHARMA GMBH11 citations69
US6414030B1Jul 2, 2002

Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers

AVENTIS PHARMA GMBH6 citations62
US6723751B1Apr 20, 2004

Crystalline forms of the sodium salt of 5-chloro-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonylpenyl)ethyl)benzamide

AVENTIS PHARMA GMBH2 citations61
US6908947B2Jun 21, 2005

Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them

AVENTIS PHARMA GMBH0 citations52
US6333349B1Dec 25, 2001

Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them

AVENTIS PHARMA GMBH1 citations52

HOECHST MARION ROUSSEL DE GMBH

4 patents

SANOFI AVENTIS DEUTSCHLAND

2 patents

ZEDIRA GMBH

1 patent

HACHTEL STEPHANIE

1 patent

BOHME THOMAS

1 patent